2026 Annual Meeting | C51 - Alzheimer's Disease
| 07:00 AM - 07:10 AM CDT | Introduction |
Alzheimer Disease Updates on Diagnosis and Treatment
Eric M. McDade, DO |
| 07:10 AM - 07:40 AM CDT | Speaker |
Fluid Biomarkers in the Diagnosis and Treatment of Alzheimer’s Disease
Suzanne E. Schindler, MD, PhD |
| 07:40 AM - 08:10 AM CDT | Speaker |
Real World Experience with Anti-amyloid Immunotherapy for the Treatment of Alzheimer's Disease
Eric M. McDade, DO |
| 08:10 AM - 08:40 AM CDT | Speaker |
Causes and Treatment of Sleep Disorders in Alzheimer's Disease
|
| 08:40 AM - 09:00 AM CDT | Q&A |
Questions and Answers
Eric M. McDade, DO |
| Eric M. McDade, DO | Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzamend. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche-Genentech. The institution of Dr. McDade has received research support from NIA. The institution of Dr. McDade has received research support from Eli Lilly. The institution of Dr. McDade has received research support from Hoffman-La Roche. The institution of Dr. McDade has received research support from Eisai. The institution of Dr. McDade has received research support from Eisai. Dr. McDade has received intellectual property interests from a discovery or technology relating to health care. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Fondation Alzheimer. |
| Suzanne E. Schindler, MD, PhD | Dr. Schindler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Schindler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schindler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. The institution of Dr. Schindler has received research support from National Institute on Aging. Dr. Schindler has received personal compensation in the range of $0-$499 for serving as a Member of the Biospecimen Review Committee with National Centralized Repository for Alzheimer Disease. Dr. Schindler has a non-compensated relationship as a Board Member with Greater Missouri Alzheimer's Association that is relevant to AAN interests or activities. |